SOD1 and amyotrophic lateral sclerosis: In the treatment of ALS, ASC-Exo has been shown to save mitochondria-related dysfunction, which can reduce intracellular SOD1 aggregation, regulate the cell phenotype of ALS, and can be used as a candidate drug for ALS treatment (Lee et al., 2016a).